Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1988 Nov 1;139(9):835–836.

The ethics of physician-pharmaceutical company relationships.

W G Thompson 1
PMCID: PMC1268336  PMID: 3179887

Full text

PDF
835

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergeron M. G., Ahronheim G., Richard J. E., Riding K., Cron C., Bryer D., Macdonald N., Bouchard M., Young J., Dempsey E. E. Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial. Pediatr Infect Dis J. 1987 Jul;6(7):654–660. doi: 10.1097/00006454-198707000-00007. [DOI] [PubMed] [Google Scholar]
  2. Bergeron M. G. The future of new oral antibiotics including the quinolones. CMAJ. 1988 Jan 1;138(1):35–42. [PMC free article] [PubMed] [Google Scholar]
  3. Rodriguez W. J., Schwartz R. H., Sait T., Khan W. N., Chhabra O. P., Chang M. J., Reddy S., Marks L. A., Gold A. J. Erythromycin-sulfisoxazole vs amoxicillin in the treatment of acute otitis media in children. A double-blind, multiple-dose comparative study. Am J Dis Child. 1985 Aug;139(8):766–770. doi: 10.1001/archpedi.1985.02140100028019. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES